Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:abbreviation |
gptkb:CNBG
|
| gptkbp:affiliatedWith |
gptkb:Chinese_government
|
| gptkbp:CEO |
Yang Xiaoming
|
| gptkbp:country |
gptkb:China
|
| gptkbp:developedBy |
gptkb:Sinopharm_BIBP_COVID-19_vaccine
gptkb:Sinopharm_WIBP_COVID-19_vaccine |
| gptkbp:founded |
1919
|
| gptkbp:headquartersLocation |
gptkb:Beijing
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sinopharm CNBG
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:nativeName |
中国生物技术集团有限公司
|
| gptkbp:notableProduct |
gptkb:WIBP-CorV
gptkb:BBIBP-CorV |
| gptkbp:numberOfEmployees |
over 11,000
|
| gptkbp:operatesIn |
global markets
|
| gptkbp:parentCompany |
gptkb:Sinopharm
|
| gptkbp:products |
medical devices
vaccines biopharmaceuticals |
| gptkbp:researchInterest |
vaccine development
biological products |
| gptkbp:subsidiary |
gptkb:China_National_Pharmaceutical_Group
|
| gptkbp:type |
gptkb:state-owned_enterprise
|
| gptkbp:website |
http://www.cnbg.com.cn/
|
| gptkbp:bfsParent |
gptkb:Sinopharm_Group_Co.,_Ltd.
|
| gptkbp:bfsLayer |
7
|